Thorsten Rieckmann

1.8k citations

55 papers · 1.5k · 1 hit paper · h-index 21

Impact in

Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
Oncology top 5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers

Papers in

Otorhinolaryngology 13
- Head and Neck Cancer Studies 13
Oncology 25
- PARP inhibition in cancer therapy 8
- Lung Cancer Research Studies 5
- Cancer-related Molecular Pathways 5

Co-authors: Malte Kriegs (27 shared papers)Ekkehard Dikomey (15 shared papers)Chia‐Jung Busch (14 shared papers)Cordula Petersen (16 shared papers)Silke Tribius (3 shared papers)Tobias J. Grob (3 shared papers)Kai Rothkamm (23 shared papers)Jochen Dahm‐Daphi (5 shared papers)
Journals: Radiotherapy and Oncology (8 papers)Oncotarget (5 papers)Cancers (3 papers)Strahlentherapie und Onkologie (3 papers)Frontiers in Oncology (3 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Thorsten Rieckmann

54 papers receiving 1.5k citations

Thorsten Rieckmann's Hit Papers

align trajectories log scale

HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity 2013 · 274 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2013 Radiotherapy and Oncology

Peers

Countries citing papers authored by Thorsten Rieckmann

Since Specialization

Citations

This map shows the geographic impact of Thorsten Rieckmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Rieckmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Rieckmann more than expected).

Fields of papers citing papers by Thorsten Rieckmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Rieckmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Rieckmann. The network helps show where Thorsten Rieckmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Thorsten Rieckmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thorsten Rieckmann Line = papers co-authored together Thorsten Rieckmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity Radiotherapy and Oncology ·Thorsten Rieckmann, Silke Tribius, Tobias J. Grob, Felix Benjamin Meyer, Chia‐Jung Busch, Cordula Petersen, Ekkehard Dikomey, Malte Kriegs Hit paper breakdown →	2013	274
2	The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining DNA repair ·Malte Kriegs, Ulla Kasten-Pisula, Thorsten Rieckmann, Katharina Holst, Jarob Saker, Jochen Dahm‐Daphi, Ekkehard Dikomey	2010	104
3	Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma Radiotherapy and Oncology ·Wael Yassin Mansour, Natalia Bogdanova, Ulla Kasten-Pisula, Thorsten Rieckmann, Sabrina Köcher, Kerstin Borgmann, Michael A. Baumann, Mechthild Krause	2012	64
4	Current studies of immunotherapy in head and neck cancer Clinical Otolaryngology ·V. Doğan, Thorsten Rieckmann, Adrian Muenscher, Chia‐Jung Busch	2017	60
5	EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma Oncogene ·Nina Struve, Zev A. Binder, Lucy F. Stead, Tim Brend, Stephen Joseph Bagley, Claire Faulkner, Leonie Florence Ott, Justus Müller-Goebel	2020	55
6	In tumor cells regulation of DNA double strand break repair through EGF receptor involves both NHEJ and HR and is independent of p53 and K-Ras status Radiotherapy and Oncology ·Laura Myllynen, Thorsten Rieckmann, Jochen Dahm‐Daphi, Ulla Kasten-Pisula, Cordula Petersen, Ekkehard Dikomey, Malte Kriegs	2011	51
7	The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines Radiotherapy and Oncology ·Julian David Güster, Stephanie Weißleder, Chia‐Jung Busch, Malte Kriegs, Cordula Petersen, Rainald Knecht, Ekkehard Dikomey, Thorsten Rieckmann	2014	49
8	Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest Radiotherapy and Oncology ·Malte Kriegs, Kristin Gurtner, Yildiz Can, Thorsten Rieckmann, Reinhard Oertel, Marek Wysocki, Franziska Dorniok, Andreas Gal	2015	49
9	Analyzing expression and phosphorylation of the EGF receptor in HNSCC Scientific Reports ·Malte Kriegs, Till Sebastian Clauditz, Konstantin Hoffer, Joanna Bartels, Sophia Buhs, Helwe Gerull, Henrike Barbara Zech, Lara Bußmann	2019	45
10	G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1 Radiotherapy and Oncology ·Chia‐Jung Busch, Marie Sophie Kröger, Jana Jensen, Malte Kriegs, Fruzsina Gatzemeier, Cordula Petersen, Adrian Muenscher, Kai Rothkamm	2016	44
11	Radiation-induced double-strand breaks require ATM but not Artemis for homologous recombination during S-phase Nucleic Acids Research ·Sabrina Köcher, Thorsten Rieckmann, Gabor Rohaly, Wael Yassin Mansour, Ekkehard Dikomey, Irena Dornreiter, Jochen Dahm‐Daphi	2012	42
12	Characterization of the first FGFRL1 mutation identified in a craniosynostosis patient Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Thorsten Rieckmann, Lei Zhuang, Christa Flueck, Beat Trüeb	2008	41
13	The cell surface receptor FGFRL1 forms constitutive dimers that promote cell adhesion Experimental Cell Research ·Thorsten Rieckmann, Ivana Kotevic, Beat Trüeb	2007	40
14	HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1 Radiotherapy and Oncology ·Chia‐Jung Busch, Malte Kriegs, Simon A. Laban, Silke Tribius, Rainald Knecht, Cordula Petersen, Ekkehard Dikomey, Thorsten Rieckmann	2013	38
15	Impact of HPV status on treatment of squamous cell cancer of the oropharynx: What we know and what we need to know Cancer Letters ·Silke Tribius, Anna Sophie Ihloff, Thorsten Rieckmann, Cordula Petersen, Markus Hoffmann	2011	36
16	Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Radiosensitivity of Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Due to Suppressed Double-Strand Break (DSB) Repair by Non-Homologous End Joining Cancers ·Ulrike Schötz, Viola Balzer, Friedrich-Wilhelm Brandt, Frank Ziemann, Florentine S. B. Subtil, Thorsten Rieckmann, Sabrina Köcher, Rita Engenhart‐Cabillic	2020	36
17	Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines Oncotarget ·Chia‐Jung Busch, Benjamin Valentin Becker, Malte Kriegs, Fruzsina Gatzemeier, Katharina Krüger, Nikolaus Möckelmann, Gerhard Fritz, Cordula Petersen	2016	29
18	Rapid Fusion and Syncytium Formation of Heterologous Cells upon Expression of the FGFRL1 Receptor Journal of Biological Chemistry ·Florian Steinberg, Simon D. Gerber, Thorsten Rieckmann, Beat Trüeb	2010	27
19	Fish possess multiple copies of fgfrl1, the gene for a novel FGF receptor Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Beat Trüeb, Stephan C. F. Neuhauss, Stefan Baertschi, Thorsten Rieckmann, Christof Schild, Sara Taeschler	2004	26
20	The inflammation-reducing compatible solute ectoine does not impair the cytotoxic effect of ionizing radiation on head and neck cancer cells Scientific Reports ·Thorsten Rieckmann, Fruzsina Gatzemeier, Sabrina Christiansen, Kai Rothkamm, Adrian Muenscher	2019	23

About Thorsten Rieckmann

Thorsten Rieckmann is a scholar working on Otorhinolaryngology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (13 papers), DNA Repair Mechanisms (12 papers), PARP inhibition in cancer therapy (8 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers), Cancer-related Molecular Pathways (5 papers), Fibroblast Growth Factor Research (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Otorhinolaryngology (285 citations), Oncology (546 citations), Cancer Research (219 citations), Molecular Biology (723 citations) and Pulmonary and Respiratory Medicine (192 citations). Thorsten Rieckmann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Malte Kriegs, Ekkehard Dikomey, Chia‐Jung Busch, Cordula Petersen, Silke Tribius, Tobias J. Grob, Kai Rothkamm, Jochen Dahm‐Daphi, Beat Trüeb and Felix Benjamin Meyer. Their work appears in journals such as Radiotherapy and Oncology, Oncotarget, Cancers, Strahlentherapie und Onkologie and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Thorsten Rieckmann

Impact in

Papers in i

In The Last Decade

Thorsten Rieckmann

Thorsten Rieckmann's Hit Papers

Peers

Countries citing papers authored by Thorsten Rieckmann

Fields of papers citing papers by Thorsten Rieckmann

All Works

About Thorsten Rieckmann

Explore authors with similar magnitude of impact

Papers in